indication-dossier
Warn
Audited by Snyk on Sep 8, 2026
Risk Level: MEDIUM
Full Analysis
MEDIUM W011: Third-party content exposure detected (indirect prompt injection risk).
- Third-party content exposure detected (low risk: 0.10). The workflow gathers evidence from literature, clinical trials, Open Targets, ChEMBL, CIViC, ClinGen, cBioPortal, DepMap/COSMIC, and other Feynman Bio Tools, which ingest external scientific literature and public database records authored by third parties.
Issues (1)
W011
MEDIUMThird-party content exposure detected (indirect prompt injection risk).
Audit Metadata